1Qiu W,Zheng l,,Gu H ,et al. Comparison between adult and infant lung injury in a rabbit ischemia- reperfusion model[ J]. J Tborac Cardiovasc Surg,2008,136 ( 2 ) : 352 - 359.
2Remadi JP, Rakotoarivelo Z, Marticho P, et al. Prospective randomized study comparing coronary artery bypass grafting with the new mini - extracorpooreal circulation Jostra System or with a standard cardiopulmonary bypass[J]. Am Heart J,2006,151 ( 1 ) :198.
3Zimmermann N, Gams E, Hohlfeld T. Aspirin in coronary artery bypass surgery:New aspects of and alternatives for an old antithrombotic agent [J]. Eur J Cardio thorac Surg,2008,34( 1 ) :93 - 108.
4Vogt S, Sattler A, Sirat AS,et al. Different profile of antioxidative capacity results in pulmonary dysfunction and amplified inflammatory response after CABG surgery[ J]. J Surg Res,2007,139( 1 ) :136 - 142.
5Chen YF,Tsai WC,Lin CC ,et al. Effect of leukocyte depletion on endothelial cell activation and transendothelial migration of leukoeytes during cardiopulmonary bypass [ J ]. Ann Thorac Surg,2004,78 ( 2 ) :634 - 642.
6Efstathiou A, Vlachveis M ,Tsonis G ,et al. Does leukodepletion during elective cardiac surgery really influence the overall clinical outcome [ J ] ? J Cardiovasc Surg(Torino) ,2003,44( 2 ) : 197 - 204.
9Lazar HL, Bokesch PM, van Lenta F, et al. Soluble human complement receptor 1 limits ischemie damage in cardiac surgery patients at high risk requiring cardiopulmonary bypass [ J ]. Circulation, 2004,110 ( 11 suppl 1 ) : II 274 - II 279.
10Golub LM,Payne JB, Reinhardt RA,et al. Can systemic diseases Co-induce ( Not Just Exacerbate) Periodontitis? A Hypothetical" Two - hit" Model[J]. J Dent Res,2006,85(2) :102 - 105.
8[1]Howard RJ,Crain C, Franzini DA,et al.Effects of cardiopulmonary bypass on pulmonary leukostasis and complement activation[J].Arch Surg,1988,123:1496-1501.
9[2]Frering B, Philip I,Dehoux M, et al. Circulating cytokines in patients undergoing normothermic cardiopulmonary bypass[J].J Thorac Cardiovasc Surg,1994,108:636-641.
10[3]Serraf A, Robotin M, Bonnet N,et al.Alteration of the neonatal pulmonary physiology agter total cardiopulmonary bypass[J].Thorac Cardiovasc Surg,1997,114:1061-1069.
5Pullamsetti SS,Savai R,Janssen W,et al. Inflammation,immunologicalreaction and role of infection in pulmonary hypertension [J]. Clin Mi-crobiol Infect,2011,17( 1) :7-14.
6Charette K, Hirata Y, Bograd A, et al. 180ml and less:cardiopul- monary bypass techniques to minimize hemodilution for neonates and small infants [ J ]. Perfusion, 2007,22 ( 5 ) :327.
7Gruenwald CE, McCrindle BW, Crawford-Lean L, et al. Reconsti- tuted fresh whole blood improves clinical outcomes compared with stored component blood therapy for neonates undergoing cardiopul- monary bypass for cardiac surgery: a randomized controlled trial [J]. Thorac Cardiovasc Surg, 2008,136(6) :1442.
8Ranucci M, Carlucci C, Boncilli A, et al. Duration of red blood cell storage and outcomes in pediatric cardiac surgery :an association found for pump prime bloodl[J]. Crit Care. 2009,13(6) :207.
9Rasmussen BS, Sollid J, Knudsen L, et al. The release of system- ic inflammatory mediators is independent of cardiopulmonary bypass temperrature [ J . J Cardiothorae Vase Aneth, 2007,21 ( 2 ) : 191.
10Allan CK, Newburger JW, McGrath E, et al. The relationship be- tween inflammatory activation and clinical outcome after infant car- diopulmonary bypass[J]. Anesth Analg, 2010,111(5) :1244.
